Clinical evaluation of pramipexole in advanced Parkinson's disease: Results of a double-blind, placebo-controlled, parallel-group study

Neurology ◽

10.1212/wnl.49.1.162 ◽

1997 ◽

Vol 49 (1) ◽

pp. 162-168 ◽

Author(s):

A. Lieberman ◽

A. Ranhosky ◽

D. Korts

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Clinical Evaluation ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Download Full-text

Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study

Journal of Neurology Neurosurgery & Psychiatry ◽

10.1136/jnnp.66.4.436 ◽

1999 ◽

Vol 66 (4) ◽

pp. 436-441 ◽

Author(s):

M M Pinter ◽

O Pogarell ◽

W H Oertel

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Multicentre Study ◽

Dopamine Agonist ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Double Blind Placebo

Download Full-text

A double-blind, placebo-controlled, randomized, multi-center study of pramipexole in advanced Parkinson's disease

European Journal of Neurology ◽

10.1046/j.1468-1331.1998.530235.x ◽

1998 ◽

Vol 5 (3) ◽

pp. 235-242 ◽

Author(s):

L. Wermuth ◽

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Double Blind Placebo ◽

Multi Center Study ◽

Download Full-text

Alpha-dihydroergocryptine in Parkinson's disease: a multiceuntre randomized double blind parallel group study

Acta Neurologica Scandinavica ◽

10.1111/j.1600-0404.1999.tb00655.x ◽

2009 ◽

Vol 99 (1) ◽

pp. 36-42 ◽

Author(s):

L. Battistin ◽

P. G. Bardin ◽

F. Ferro-Milone ◽

C. Ravenna ◽

V. Toso ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Double Blind ◽

Parallel Group Study ◽

Download Full-text

GW24-e0014 Analysis on clinical evaluation of parkinson’s disease with interated traditional chinese and western medicine therapy: a multicenter, randomized, double-blind, placebo controlled trial

Heart ◽

10.1136/heartjnl-2013-304613.389 ◽

2013 ◽

Vol 99 (Suppl 3) ◽

pp. A141.2-A141

Author(s):

Yang Bo ◽

Li Min ◽

Yang Bo

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Clinical Evaluation ◽

Western Medicine ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Rotigotine transdermal patch in Chinese patients with advanced Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study

Parkinsonism & Related Disorders ◽

10.1016/j.parkreldis.2017.08.015 ◽

2017 ◽

Vol 44 ◽

pp. 6-12 ◽

Author(s):

Zhen-Xin Zhang ◽

Chun-Feng Liu ◽

En-Xiang Tao ◽

Ming Shao ◽

Yi-Ming Liu ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Chinese Patients ◽

Transdermal Patch ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Double Blind Placebo ◽

Pivotal Study ◽

Rotigotine Transdermal Patch

Download Full-text

Subcutaneous apomorphine in patients with advanced Parkinson's disease: A dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single dose

Journal of the Neurological Sciences ◽

10.1016/j.jns.2007.03.013 ◽

2007 ◽

Vol 258 (1-2) ◽

pp. 137-143 ◽

Author(s):

Rajesh Pahwa ◽

William C. Koller ◽

Richard M. Trosch ◽

James H. Sherry

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Single Dose ◽

Dose Escalation ◽

Dose Escalation Study ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Double Blind Placebo ◽

Subcutaneous Apomorphine

Download Full-text

The efficacy and safety of pramipexole ER versus IR in Chinese patients with Parkinson’s disease: a randomized, double-blind, double-dummy, parallel-group study

Translational Neurodegeneration ◽

10.1186/2047-9158-3-11 ◽

2014 ◽

Vol 3 (1) ◽

pp. 11 ◽

Author(s):

Ying Wang ◽

Shenggang Sun ◽

Suiqiang Zhu ◽

Chunfeng Liu ◽

Yiming Liu ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Chinese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Parallel Group Study ◽

Download Full-text

Transdermal rotigotine in advanced Parkinson’s disease: a randomized, double-blind, placebo-controlled trial

Journal of Neurology ◽

10.1007/s00415-014-7427-3 ◽

2014 ◽

Vol 261 (10) ◽

pp. 1887-1893 ◽

Author(s):

Masahiro Nomoto ◽

Yoshikuni Mizuno ◽

Tomoyoshi Kondo ◽

Kazuko Hasegawa ◽

Miho Murata ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Controlled Trial ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Double Blind Placebo

Download Full-text

A randomised, double-blind, placebo controlled, parallel group study of the standardised extract SHR-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue

Planta Medica ◽

10.1055/s-0029-1235006 ◽

2009 ◽

Vol 75 (09) ◽

Author(s):

EMG Olsson ◽

B von Schéele ◽

AG Panossian

Keyword(s):

Rhodiola Rosea ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717995300.793478299 ◽

2013 ◽

Author(s):

Altaf Mangera

Keyword(s):

Low Dose ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Orally Disintegrating Tablet ◽

Parallel Group Study ◽

Download Full-text